Molecular Imaging and Biology

, Volume 15, Issue 3, pp 299–306

Functionalized Magnetonanoparticles in Visualization of Intracranial Tumors on MRI


    • Jane and Terry Semel Institute for Neuroscience and Human Behavior, David Geffen school of MedicineUniversity of California
  • Whitney Pope
    • Department of Radiology, David Geffen School of MedicineUniversity of California
  • Gary Mathern
    • Department of Neurosurgery, David Geffen School of MedicineUniversity of California
  • Rex Moats
    • Department of Radiology, Children’s Hospital of Los AngelesUniversity of Southern California
  • Andrew Frew
    • Department of Neurosurgery, David Geffen School of MedicineUniversity of California
  • Mark Mandelkern
    • Department of PhysicsUniversity of California
Research Article

DOI: 10.1007/s11307-012-0601-z

Cite this article as:
Akhtari, M., Pope, W., Mathern, G. et al. Mol Imaging Biol (2013) 15: 299. doi:10.1007/s11307-012-0601-z



The development of nonradioactive and targeted magnetonanoparticles (MNP) capable of crossing the blood–brain barrier (BBB) and of concentrating in and enhancing the contrast of intracranial tumors on magnetic resonance imaging (MRI).


Nonradioactive 2-deoxy-d-glucose (2DG) was covalently attached to magnetonanoparticles composed of iron oxide and dextran and prepared for intravenous (tail) injection in the naïve rats and mouse models of glioma. MR images were acquired at 3 and 7 T.


2DG-MNP increased tumor visibility and improved delineation of tumor margins. Histopathology confirmed that 2DG-MNP crossed the BBB and accumulated within brain parenchyma.


Nonradioactive 2DG-MNP can cross an intact BBB on and improve visualization of tumor and tumor margins on MRI.

Key words


Copyright information

© World Molecular Imaging Society 2012